Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

microdosing

  • You have access
    The Use of Microdosing in the Development of Small Organic and Protein Therapeutics
    Mats Bergstrom
    Journal of Nuclear Medicine August 1, 2017, 58 (8) 1188-1195; DOI: https://doi.org/10.2967/jnumed.116.188037
  • You have access
    Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats
    Tal Burt, Douglas C. Rouse, Kihak Lee, Huali Wu, Anita T. Layton, Thomas C. Hawk, Douglas H. Weitzel, Bennett B. Chin, Michael Cohen-Wolkowiez, Shein-Chung Chow and Robert J. Noveck
    Journal of Nuclear Medicine November 1, 2015, 56 (11) 1793-1799; DOI: https://doi.org/10.2967/jnumed.115.160986
  • You have access
    The Role of Exploratory Investigational New Drugs for Translating Radiopharmaceuticals into First-in-Human Studies
    Sally W. Schwarz and Reiko Oyama
    Journal of Nuclear Medicine April 1, 2015, 56 (4) 497-500; DOI: https://doi.org/10.2967/jnumed.114.146472
  • You have access
    Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
    Derrek A. Heuveling, Remco de Bree, Danielle J. Vugts, Marc C. Huisman, Leonardo Giovannoni, Otto S. Hoekstra, C. René Leemans, Dario Neri and Guus A.M.S. van Dongen
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 397-401; DOI: https://doi.org/10.2967/jnumed.112.111310
SNMMI

© 2025 SNMMI

Powered by HighWire